A Bioavailability Study of Rifabutin and Lopinavir/Ritonavir in Healthy Adult Subjects

NCT00743470 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

15

Enrollment

INDUSTRY

Sponsor class

Conditions

HIV
Tuberculosis

Interventions

DRUG: lopinavir/ritonavir
DRUG: rifabutin

Sponsor

Abbott